Recruiting

Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer

This study evaluates the genomic profiles of breast cancer in a prospective and population-based manner. In the first phase, breast tumors are analyzed by whole transcriptome RNA-sequencing. Gene expression profiles, mutational profiles, and transcript isoform-level data will be analyzed in the context of patient information, clinicopathological variables, and outcome, with the purpose to develop new molecular diagnostic assays for breast cancer. Additional genome-scale RNA, DNA, and protein analyses will be…

ClinicalTrials.gov IDNCT02306096

PhaseNot Applicable

Enrollment20000

SponsorLund University

AgeNo minimum reported

SexALL

I'm interested View official listing

Conditions studied

Breast Neoplasms

About this study

Primary outcomes

Biomarkers and clinicopathological information (up to 20-years)
Invasive disease-free survival (up to 20-years)

Eligibility information

Inclusion Criteria: * suspicion or confirmed diagnosis of primary breast cancer * signed informed consent Exclusion Criteria: * lack of signed informed consent

Study locations

Södra Älvsborg Hospital, Borås, Sweden
Hallands Hospital Halmstad, Halmstad, 30233 Sweden
Helsingborg Hospital, Helsingborg, 25187 Sweden
Kirurgiska kliniken, Jönköping, 55185 Sweden
Blekinge County Hospital, Karlskrona, 37185 Sweden
Central Hospital Kristianstad, Kristianstad, 29185 Sweden
Skåne University Hospital, Lund, 22185 Sweden
Skåne University Hospital, Malmö, 20502 Sweden
Uppsala University Hospital, Uppsala, 75185 Sweden
Central Hospital Växjö, Vaxjo, 35234 Sweden

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.